Cargando…

Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types

BACKGROUND: microRNAs (miRNAs) regulate target genes at the post-transcriptional level and play important roles in cancer pathogenesis and development. Variation amongst individuals is a significant confounding factor in miRNA (or other) expression studies. The true character of biologically or clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Navon, Roy, Wang, Hui, Steinfeld, Israel, Tsalenko, Anya, Ben-Dor, Amir, Yakhini, Zohar
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777376/
https://www.ncbi.nlm.nih.gov/pubmed/19946373
http://dx.doi.org/10.1371/journal.pone.0008003
_version_ 1782174178790604800
author Navon, Roy
Wang, Hui
Steinfeld, Israel
Tsalenko, Anya
Ben-Dor, Amir
Yakhini, Zohar
author_facet Navon, Roy
Wang, Hui
Steinfeld, Israel
Tsalenko, Anya
Ben-Dor, Amir
Yakhini, Zohar
author_sort Navon, Roy
collection PubMed
description BACKGROUND: microRNAs (miRNAs) regulate target genes at the post-transcriptional level and play important roles in cancer pathogenesis and development. Variation amongst individuals is a significant confounding factor in miRNA (or other) expression studies. The true character of biologically or clinically meaningful differential expression can be obscured by inter-patient variation. In this study we aim to identify miRNAs with consistent differential expression in multiple tumor types using a novel data analysis approach. METHODS: Using microarrays we profiled the expression of more than 700 miRNAs in 28 matched tumor/normal samples from 8 different tumor types (breast, colon, liver, lung, lymphoma, ovary, prostate and testis). This set is unique in putting emphasis on minimizing tissue type and patient related variability using normal and tumor samples from the same patient. We develop scores for comparing miRNA expression in the above matched sample data based on a rigorous characterization of the distribution of order statistics over a discrete state set, including exact p-values. Specifically, we compute a Rank Consistency Score (RCoS) for every miRNA measured in our data. Our methods are also applicable in various other contexts. We compare our methods, as applied to matched samples, to paired t-test and to the Wilcoxon Signed Rank test. RESULTS: We identify consistent (across the cancer types measured) differentially expressed miRNAs. 41 miRNAs are under-expressed in cancer compared to normal, at FDR (False Discovery Rate) of 0.05 and 17 are over-expressed at the same FDR level. Differentially expressed miRNAs include known oncomiRs (e.g miR-96) as well as miRNAs that were not previously universally associated with cancer. Specific examples include miR-133b and miR-486-5p, which are consistently down regulated and mir-629* which is consistently up regulated in cancer, in the context of our cohort. Data is available in GEO. Software is available at: http://bioinfo.cs.technion.ac.il/people/zohar/RCoS/
format Text
id pubmed-2777376
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-27773762009-11-26 Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types Navon, Roy Wang, Hui Steinfeld, Israel Tsalenko, Anya Ben-Dor, Amir Yakhini, Zohar PLoS One Research Article BACKGROUND: microRNAs (miRNAs) regulate target genes at the post-transcriptional level and play important roles in cancer pathogenesis and development. Variation amongst individuals is a significant confounding factor in miRNA (or other) expression studies. The true character of biologically or clinically meaningful differential expression can be obscured by inter-patient variation. In this study we aim to identify miRNAs with consistent differential expression in multiple tumor types using a novel data analysis approach. METHODS: Using microarrays we profiled the expression of more than 700 miRNAs in 28 matched tumor/normal samples from 8 different tumor types (breast, colon, liver, lung, lymphoma, ovary, prostate and testis). This set is unique in putting emphasis on minimizing tissue type and patient related variability using normal and tumor samples from the same patient. We develop scores for comparing miRNA expression in the above matched sample data based on a rigorous characterization of the distribution of order statistics over a discrete state set, including exact p-values. Specifically, we compute a Rank Consistency Score (RCoS) for every miRNA measured in our data. Our methods are also applicable in various other contexts. We compare our methods, as applied to matched samples, to paired t-test and to the Wilcoxon Signed Rank test. RESULTS: We identify consistent (across the cancer types measured) differentially expressed miRNAs. 41 miRNAs are under-expressed in cancer compared to normal, at FDR (False Discovery Rate) of 0.05 and 17 are over-expressed at the same FDR level. Differentially expressed miRNAs include known oncomiRs (e.g miR-96) as well as miRNAs that were not previously universally associated with cancer. Specific examples include miR-133b and miR-486-5p, which are consistently down regulated and mir-629* which is consistently up regulated in cancer, in the context of our cohort. Data is available in GEO. Software is available at: http://bioinfo.cs.technion.ac.il/people/zohar/RCoS/ Public Library of Science 2009-11-25 /pmc/articles/PMC2777376/ /pubmed/19946373 http://dx.doi.org/10.1371/journal.pone.0008003 Text en Navon et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Navon, Roy
Wang, Hui
Steinfeld, Israel
Tsalenko, Anya
Ben-Dor, Amir
Yakhini, Zohar
Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types
title Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types
title_full Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types
title_fullStr Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types
title_full_unstemmed Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types
title_short Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types
title_sort novel rank-based statistical methods reveal micrornas with differential expression in multiple cancer types
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777376/
https://www.ncbi.nlm.nih.gov/pubmed/19946373
http://dx.doi.org/10.1371/journal.pone.0008003
work_keys_str_mv AT navonroy novelrankbasedstatisticalmethodsrevealmicrornaswithdifferentialexpressioninmultiplecancertypes
AT wanghui novelrankbasedstatisticalmethodsrevealmicrornaswithdifferentialexpressioninmultiplecancertypes
AT steinfeldisrael novelrankbasedstatisticalmethodsrevealmicrornaswithdifferentialexpressioninmultiplecancertypes
AT tsalenkoanya novelrankbasedstatisticalmethodsrevealmicrornaswithdifferentialexpressioninmultiplecancertypes
AT bendoramir novelrankbasedstatisticalmethodsrevealmicrornaswithdifferentialexpressioninmultiplecancertypes
AT yakhinizohar novelrankbasedstatisticalmethodsrevealmicrornaswithdifferentialexpressioninmultiplecancertypes